Berkeley Lights to Participate in the Cowen 41st Annual Healthcare Conference

Berkeley Lights, a leader in Digital Cell Biology, will participate in the Cowen 41st Annual Healthcare Conference on March 4 at 11:10 a.m. PT.

Rhea-AI Summary

Berkeley Lights, a leader in Digital Cell Biology, will participate in the Cowen 41st Annual Healthcare Conference on March 4 at 11:10 a.m. PT. The management will engage in a fireside chat, providing insights into the company's advancements in biotherapeutics and cell-based products. Interested stakeholders can access a live and archived webcast of the presentation on their official website. Berkeley Lights is known for its innovative platform that enhances the development and commercialization of biotherapeutics through advanced automation and analysis of single cells.

Argus Session date unavailable

-8.28% session move Open Argus

Details

News Market Reaction – BLI

The recorded move for BLI in the trading session of this news was -8.28%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EMERYVILLE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming Cowen 41^st Annual Healthcare Conference.

Berkeley Lights’ management is scheduled to participate in a fireside chat on Thursday, March 4 at 11:10 a.m. Pacific Time / 2:10 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.berkeleylights.com.

About Berkeley Lights
Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.

Berkeley Lights’ Beacon^® and Lightning^™ systems and Culture Station^™ instrument are FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.

Press Contact
berkeleylights@bulleitgroup.com

Investor Contact
ir@berkeleylights.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Berkeley Lights participating in the Cowen 41st Annual Healthcare Conference?

Berkeley Lights will participate in the Cowen 41st Annual Healthcare Conference on March 4 at 11:10 a.m. Pacific Time.

How can I access the webcast of Berkeley Lights' presentation?

You can access the live and archived webcast of Berkeley Lights' presentation on the 'Investors' section of their website.

What is the focus of Berkeley Lights as a company?

Berkeley Lights focuses on enabling and accelerating the development and commercialization of biotherapeutics and cell-based products.

What systems does Berkeley Lights offer for research?

Berkeley Lights offers the Beacon® and Lightning™ systems as well as the Culture Station™ instrument for research use only.

What is the stock symbol for Berkeley Lights?

The stock symbol for Berkeley Lights is BLI.